These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21104342)

  • 1. Significance of epidermal growth factor receptor expression in breast cancer.
    Badovinac-Crnjevic T; Jakic-Razumovic J; Podolski P; Pleština S; Sarčević B; Munjas R; Vrbanec D
    Med Oncol; 2011 Dec; 28 Suppl 1():S121-8. PubMed ID: 21104342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patients.
    DiGiovanna MP; Stern DF; Edgerton SM; Whalen SG; Moore D; Thor AD
    J Clin Oncol; 2005 Feb; 23(6):1152-60. PubMed ID: 15718311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma.
    Abd El-Rehim DM; Pinder SE; Paish CE; Bell JA; Rampaul RS; Blamey RW; Robertson JF; Nicholson RI; Ellis IO
    Br J Cancer; 2004 Oct; 91(8):1532-42. PubMed ID: 15480434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors.
    Tolgay Ocal I; Dolled-Filhart M; D'Aquila TG; Camp RL; Rimm DL
    Cancer; 2003 Apr; 97(8):1841-8. PubMed ID: 12673709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexpression of the type 1 growth factor receptor family members HER-1, HER-2, and HER-3 has a synergistic negative prognostic effect on breast carcinoma survival.
    Wiseman SM; Makretsov N; Nielsen TO; Gilks B; Yorida E; Cheang M; Turbin D; Gelmon K; Huntsman DG
    Cancer; 2005 May; 103(9):1770-7. PubMed ID: 15770691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival.
    Suo Z; Risberg B; Kalsson MG; Willman K; Tierens A; Skovlund E; Nesland JM
    J Pathol; 2002 Jan; 196(1):17-25. PubMed ID: 11748637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ErbB-receptors expression and survival in breast carcinoma: a 15-year follow-up study.
    Bianchi S; Palli D; Falchetti M; Saieva C; Masala G; Mancini B; Lupi R; Noviello C; Omerovic J; Paglierani M; Vezzosi V; Alimandi M; Mariani-Costantini R; Ottini L
    J Cell Physiol; 2006 Mar; 206(3):702-8. PubMed ID: 16245316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic significance of epidermal growth factor receptor (EGFR), C-erbB-2, Ki-67 and PCNA expression in breast cancer.
    Ioachim E; Kamina S; Athanassiadou S; Agnantis NJ
    Anticancer Res; 1996; 16(5B):3141-7. PubMed ID: 8920782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlated expression of erbB-3 with hormone receptor expression and favorable clinical outcome in invasive ductal carcinomas of the breast.
    Lee Y; Cho S; Seo JH; Shin BK; Kim HK; Kim I; Kim A
    Am J Clin Pathol; 2007 Dec; 128(6):1041-9. PubMed ID: 18024331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer.
    Logullo AF; Lopes AB; Nonogaki S; Soares FA; Netto MM; Nishimoto IN; Brentani MM
    Oncol Rep; 2007 Jul; 18(1):121-6. PubMed ID: 17549356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of the combination of epidermal growth factor receptor and c-erbB-2 in breast cancer.
    Tsutsui S; Ohno S; Murakami S; Kataoka A; Kinoshita J; Hachitanda Y
    Surgery; 2003 Feb; 133(2):219-21. PubMed ID: 12605184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients.
    Nagai MA; Gerhard R; Fregnani JH; Nonogaki S; Rierger RB; Netto MM; Soares FA
    Breast Cancer Res Treat; 2011 Feb; 126(1):1-14. PubMed ID: 20369286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-erbB-4 protein expression in human breast cancer.
    Kew TY; Bell JA; Pinder SE; Denley H; Srinivasan R; Gullick WJ; Nicholson RI; Blamey RW; Ellis IO
    Br J Cancer; 2000 Mar; 82(6):1163-70. PubMed ID: 10735500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular coexpression of epidermal growth factor receptor, Her-2/neu, and p21ras in human breast cancers: evidence for the existence of distinctive patterns of genetic evolution that are common to tumors from different patients.
    Shackney SE; Pollice AA; Smith CA; Janocko LE; Sweeney L; Brown KA; Singh SG; Gu L; Yakulis R; Lucke JF
    Clin Cancer Res; 1998 Apr; 4(4):913-28. PubMed ID: 9563885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of the co-expression of p53 and c-erbB-2 proteins in breast cancer.
    Nakopoulou LL; Alexiadou A; Theodoropoulos GE; Lazaris AC; Tzonou A; Keramopoulos A
    J Pathol; 1996 May; 179(1):31-8. PubMed ID: 8691341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human epidermal growth factor receptor-2 family in colorectal adenocarcinoma: correlation with survival and clinicopathological findings.
    Molaei M; Pejhan S; Nayer BN; Moradi A; Ghiasi S; Zali MR
    Eur J Gastroenterol Hepatol; 2009 Mar; 21(3):289-93. PubMed ID: 19279475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective study.
    Ma BB; Poon TC; To KF; Zee B; Mo FK; Chan CM; Ho S; Teo PM; Johnson PJ; Chan AT
    Head Neck; 2003 Oct; 25(10):864-72. PubMed ID: 12966511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression.
    Anders CK; Hsu DS; Broadwater G; Acharya CR; Foekens JA; Zhang Y; Wang Y; Marcom PK; Marks JR; Febbo PG; Nevins JR; Potti A; Blackwell KL
    J Clin Oncol; 2008 Jul; 26(20):3324-30. PubMed ID: 18612148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between c-erbB-2 oncoprotein, epidermal growth factor receptor, and estrogen receptor expression in patients with ductal breast carcinoma. Association with tumor phenotypes.
    Harłoziñska A; Bar JK; Wenderski R; Bebenek M
    In Vivo; 1996; 10(2):217-22. PubMed ID: 8744803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of EGFR, c-erbB-2 product and ras p21 immunohistochemistry as prognostic markers in primary breast cancer.
    Hainsworth PJ; Henderson MA; Stillwell RG; Bennett RC
    Eur J Surg Oncol; 1991 Feb; 17(1):9-15. PubMed ID: 1671658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.